Page last updated: 2024-08-25

rosiglitazone and Experimental Radiation Injuries

rosiglitazone has been researched along with Experimental Radiation Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biti, G; Bonomo, P; Bottoncetti, A; Cassani, S; Castiglione, F; Franzese, C; Gerini, C; Greto, D; Livi, L; Mangoni, M; Masoni, T; Meattini, I; Pallotta, S; Passeri, A; Pupi, A; Sottili, M; Vanzi, E	1

Other Studies

1 other study(ies) available for rosiglitazone and Experimental Radiation Injuries

Article	Year
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model. Lung cancer (Amsterdam, Netherlands), 2015, Volume: 90, Issue:3 Topics: Animals; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Lung Injury; Mice; PPAR gamma; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiation, Ionizing; Radiotherapy; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays	2015

Article

Year

A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model.

Lung cancer (Amsterdam, Netherlands), 2015, Volume: 90, Issue:3

Topics: Animals; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Humans; Lung Injury; Mice; PPAR gamma; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiation, Ionizing; Radiotherapy; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays

2015